Results 141 to 150 of about 123,913 (326)

TEMPORAL LOBE HERNIATION AND CHIASMOPATHY DURING DOPAMINE AGONIST THERAPY FOR PROLACTINOMA. [PDF]

Acta Endocrinol (Buchar), 2023
Giraldi EA, Saindane A, Pradilla G, Biousse V, Ioachimescu AG.   +4 more
europepmc   +1 more source

The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: A novel possible model of OCD [PDF]

, 2014
Dawn M. Eagle, Cristie Noschang, Laure-Sophie Camilla d’Angelo, C Noble, Jacob Day, Marie Louise Dongelmans, David Theobald, Adam C. Mar, Gonzalo P. Urcelay, Sharon Morein‐Zamir, Trevor W. Robbins   +10 more
openalex   +1 more source

Bridging Psychological Stress and Skin Cellular Aging: Flavonoids as a Dual‐Action Therapeutic Strategy

Phytotherapy Research, EarlyView.
ABSTRACT Psychological stress (or simply “stress”) is a major contributor to chronic disease worldwide, affecting 35% of the global population, including younger generations. Furthermore, it plays a significant role in human premature aging; hence, its detrimental effects on people's health compel us to comprehend and control the ways in which ...
Marco Duarte, Sílvia Santos Pedrosa, P. Raaj Khusial, Ana Raquel Madureira   +3 more
wiley   +1 more source

Shared GABA transmission pathology in dopamine agonist- and antagonist-induced dyskinesia. [PDF]

Cell Rep Med, 2023
Abe Y, Yagishita S, Sano H, Sugiura Y, Dantsuji M, Suzuki T, Mochizuki A, Yoshimaru D, Hata J, Matsumoto M, Taira S, Takeuchi H, Okano H, Ohno N, Suematsu M, Inoue T, Nambu A, Watanabe M, Tanaka KF.   +18 more
europepmc   +1 more source

The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke [PDF]

, 2012
Nikos Gorgoraptis, Yee‐Haur Mah, Bjoern Machner, Victoria Singh‐Curry, Paresh Malhotra, Maria Hadjimichael, David Cohen, Robert Simister, Ajoy Nair, Elena Kulinskaya, Nick Ward, Richard Greenwood, Masud Husain   +12 more
openalex   +1 more source

Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation [PDF]

, 2020
Rouba Kozak, Tamás Kiss, Keith Dlugolenski, David E. Johnson, Roxanne Gorczyca, Kyle Kuszpit, Brian D. Harvey, Polina Stolyar, Stacey J. Sukoff Rizzo, William E. Hoffmann, Dmitri Volfson, Mihály Hajós, Jennifer E. Davoren, Amanda Abbott, Graham V. Williams, Stacy A. Castner, David Gray   +16 more
openalex   +1 more source

Multi‐Channel Neural Interface for Neural Recording and Neuromodulation

Small Methods, EarlyView.
This review highlights recent advances in multi‐channel neural interface technologies, covering both high‐resolution electrophysiological recording systems and multifunctional platforms with integrated capabilities. It also discusses innovations in structure and materials for reduced invasiveness, state‐of‐the‐art data analysis, including machine ...
Eunmin Kim, Won Gi Chung, Enji Kim, Myoungjae Oh, Joonho Paek, Taekyeong Lee, Dayeon Kim, Seung Hyun An, Sumin Kim, Jang‐Ung Park   +9 more
wiley   +1 more source

Dopamine autoreceptor agonists as potential antipsychotics. 1. (Aminoalkoxy)anilines

, 1988
Juan C. Jaén, Lawrence D. Wise, Thomas G. Heffner, Thomas A. Pugsley, Leonard T. Meltzer   +4 more
openalex   +1 more source

Dopamine D1 Receptor Agonist and D2 Receptor Antagonist Effects of the Natural Product (−)–Stepholidine: Molecular Modeling and Dynamics Simulations [PDF]

, 2007
Wei Fu, Jianhua Shen, Xiaomin Luo, Weiliang Zhu, Jiagao Cheng, Kunqian Yu, James M. Briggs, Guo-Zhang Jin, Kaixian Chen, Hualiang Jiang   +9 more
openalex   +1 more source

Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System [PDF]

, 2022
Michele Fusaroli, Emanuel Raschi, Valentina Giunchi, Marco Menchetti, Roberto Rimondini, Fabrizio De Ponti, Elisabetta Poluzzi   +6 more
openalex   +1 more source